Open the filing on EDGARTeradyne Reports Third Quarter 2025 Results
Revenue and earnings at the high-end of Q3 guidance
Revenue of $769 million in Q3'25, up 4% from Q3'24
Semiconductor Test drove better than expected Q3'25 results
Strong AI-related demand in Compute and Memory expected to grow in Q4'25
| Q3'25 | Q3'24 | Q2'25 |
|---|
| Revenue (mil) | $769 | $737 | $652 |
| GAAP EPS | $0.75 | $0.89 | $0.49 |
| Non-GAAP EPS | $0.85 | $0.90 | $0.57 |
NORTH READING, Mass. - October 28, 2025 - Teradyne, Inc. (NASDAQ: TER) reported revenue of $769 million for the third quarter of 2025 of which $606 million was in Semiconductor Test, $88 million in Product Test, and $75 million in Robotics. GAAP net income for the third quarter of 2025 was $119.6 million, or $0.75 per diluted share. On a non-GAAP basis, Teradyne’s net income for the third quarter of 2025 was $135.9 million, or $0.85 per diluted share, which excluded acquired intangible asset amortization, restructuring and other charges, pension mark-to-market adjustment, and included the related tax impact on non-GAAP adjustment.
“Our Semiconductor Test Group delivered third quarter sales that exceeded expectations, driving company sales and profit to the high end of our Q3 guidance range,” said Teradyne CEO, Greg Smith. “Growth was driven primarily by System-on-a-Chip (SOC) solutions for artificial intelligence applications and strong performance in memory. As we look ahead to Q4, AI-related test demand remains robust across compute, networking and memory segments. Q4'25 sales are expected to increase 25% sequentially and 27% from Q4'24."
Guidance for the fourth quarter of 2025 is revenue of $920 million to $1,000 million, with GAAP net income of $1.12 to $1.39 per diluted share and non-GAAP net income of $1.20 to $1.46 per diluted share. Non-GAAP guidance excludes acquired intangible asset amortization and amortization on our investment in Technoprobe, as well as the related tax impact on non-GAAP adjustments.
Webcast
A conference call to discuss the third quarter results, along with management’s business outlook, will follow at 8:30 a.m. ET, October 29, 2025. Interested investors should access the webcast at www.teradyne.com and click on "Investors" at least five minutes before the call begins. Presentation materials will be available starting at 7:30 a.m. ET. A replay will be available on the Teradyne website at www.teradyne.com/investors.
Non-GAAP Results
In addition to disclosing results that are determined in accordance with GAAP, Teradyne also discloses non-GAAP results of operations that exclude certain income items and charges. These results are provided as a complement to results provided in accordance with GAAP. Non-GAAP income from operations and non-GAAP net income exclude acquired intangible assets amortization, restructuring and other, ERP related expenses, inventory step-up, pension mark-to-market adjustment, pension actuarial gains and losses, discrete income tax adjustments, and includes the related tax impact on non-GAAP adjustments. GAAP requires that these items be included in determining income from operations and net income. Non-GAAP income from operations, non-GAAP net income, non-GAAP income from operations as a percentage of revenue, non-GAAP net income as a percentage of revenue, and non-GAAP net income per share are non-GAAP performance measures presented to provide meaningful supplemental information regarding Teradyne’s baseline performance before gains, losses or other charges that may not be indicative of Teradyne’s current core business or future outlook. These non-GAAP performance measures are used to make operational decisions, to determine employee compensation, to forecast future operational results, and for comparison with Teradyne’s business plan, historical operating results and the operating results of Teradyne’s competitors. Non-GAAP diluted shares include the impact of Teradyne’s call option on its shares. Management believes each of these non-GAAP performance measures provides useful supplemental information for investors, allowing greater transparency to the information used by management in its operational decision making and in the review of Teradyne’s financial and operational performance, as well as facilitating meaningful comparisons of Teradyne’s results in the current period compared with those in prior and future periods. A reconciliation of each available GAAP to non-GAAP financial measure discussed in this press release is contained in the attached exhibits and on the Teradyne website at www.teradyne.com by clicking on “Investor Relations” and then selecting “Financials” and the “GAAP to Non-GAAP Reconciliation” link. The non-GAAP performance measures discussed in this press release may not be comparable to similarly titled measures used by other companies. The presentation of non-GAAP measures is not meant to be considered in isolation, as a substitute for, or superior to, financial measures or information provided in accordance with GAAP.
About Teradyne
Teradyne (NASDAQ:TER) designs, develops, and manufactures automated test equipment and advanced robotics systems. Its test solutions for semiconductors and electronics products enable Teradyne's customers to consistently deliver on their quality standards. Its advanced robotics business includes collaborative robots and mobile robots that support manufacturing and warehouse operations for companies of all sizes. For more information, visit teradyne.com. Teradyne® is a registered trademark of Teradyne, Inc., in the U.S. and other countries.
Safe Harbor Statement
Forward-looking statements notice
This release contains forward-looking statements including statements regarding Teradyne’s future business prospects, financial performance or position and results of operations. You can identify forward-looking statements by their use of forward-looking words such as “anticipate,” “expect,” “plan,” “could,” “may,” “will,” “believe,” “estimate,” “goal” or other comparable terms. Forward-looking statements in this press release address various matters, including statements regarding Teradyne’s financial guidance. Investors are cautioned that such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements due to known and unknown risks, uncertainties, assumptions, and other factors. Such factors include, but are not limited to, macroeconomic factors and slowdowns or downturns in economic conditions generally and in the markets in which Teradyne operates; decreased or delayed product demand from one or more significant customers; a slowdown or inability in the development, delivery and acceptance of new products; the ability to grow the Robotics business; the impact of increased research and development spending; the impact of epidemics or pandemics such as COVID-19; the impact of a supply shortage on our supply chain and contract manufacturers; the consummation and success of any mergers or acquisitions; unexpected cash needs; the business judgment of the board of directors that a declaration of a dividend or the repurchase of common stock is not in Teradyne’s best interests; changes to U.S. or global tax regulations or guidance; the impact of any tariffs or export controls imposed by the U.S. or China; the impact of U.S. Department of Commerce or other government agency regulations relating to Huawei, HiSilicon and other customers or potential customers; the impact of U.S. Department Commerce export control regulations for certain U.S. products and technology sold to military end users or for military end-use in China; the impact of the current conflicts in Israel; the impact of regulations published by the U.S. Department of Commerce relating to semiconductors and semiconductor manufacturing equipment destined for certain end uses in China.
The risks included above are not exhaustive. For a more detailed description of the risk factors associated with Teradyne, please refer to Teradyne’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024. Many of these factors are macroeconomic in nature and are, therefore, beyond Teradyne’s control. We caution readers not to place undue reliance on any forward-looking statements included in this press release which speak only as to the date of this press release. Teradyne specifically disclaims any obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.
TERADYNE, INC. REPORT FOR THIRD FISCAL QUARTER OF 2025
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
| Quarter Ended | Nine Months Ended |
|---|
| September 28, 2025 | June 29, 2025 | September 29, 2024 | September 28, 2025 | September 29, 2024 |
|---|
| Net revenues | $769,210 | $651,797 | $737,298 | $2,106,687 | $2,066,996 |
| Cost of revenues (exclusive of acquired intangible assets amortization shown separately below) (1) | 319,904 | 278,785 | 300,784 | 869,032 | 865,357 |
| Gross profit | 449,306 | 373,012 | 436,514 | 1,237,655 | 1,201,639 |
| Operating expenses: | | | | | |
| Selling and administrative (2) | 169,144 | 157,782 | 157,649 | 484,182 | 461,307 |
| Engineering and development | 124,760 | 118,382 | 117,474 | 361,331 | 332,489 |
| Acquired intangible assets amortization | 3,514 | 3,733 | 4,748 | 11,820 | 14,108 |
| Restructuring and other (3) | 6,585 | 2,372 | 4,578 | 23,472 | 11,018 |
| Loss (gain) on sale of business (4) | - | - | - | - | (57,486) |
| Operating expenses | 304,003 | 282,269 | 284,449 | 880,805 | 761,436 |
| Income from operations | 145,303 | 90,743 | 152,065 | 356,850 | 440,203 |
| Interest and other (income) expense (5) | (2,797) | (5,816) | (6,919) | (6,834) | (11,086) |
| Income before income taxes | 148,100 | 96,559 | 158,984 | 363,684 | 451,289 |
| Income tax provision | 23,344 | 12,260 | 12,260 | 50,148 | 54,095 |
| Income before equity in net earnings of affiliate | $124,756 | $84,299 | $146,724 | $313,536 | $397,194 |
| Equity in net earnings of affiliate | (5,198) | (5,927) | (1,075) | (16,709) | (1,075) |
| Net income | $119,558 | $78,372 | $145,649 | $296,827 | $396,119 |
| Net income per common share: | | | | | |
| Basic | $0.75 | $0.49 | $0.89 | $1.85 | $2.51 |
| Diluted | $0.75 | $0.49 | $0.89 | $1.85 | $2.42 |
| Weighted average common shares - basic | 158,595 | 159,967 | 163,002 | 160,021 | 157,951 |
| Weighted average common shares - diluted (6) | 159,097 | 160,135 | 164,253 | 160,409 | 163,357 |
| Cash dividend declared per common share | $0.12 | $0.12 | $0.12 | $0.36 | $0.36 |
(1) Cost of revenues includes:
| Quarter Ended | Nine Months Ended |
|---|
| September 28, 2025 | June 29, 2025 | September 29, 2024 | September 28, 2025 | September 29, 2024 |
|---|
| Provision for excess and obsolete inventory | $6,829 | $7,402 | $6,078 | $19,175 | $15,515 |
| Inventory step-up | 351 | 343 | - | 910 | - |
| Legal Settlement | - | - | 3,600 | - | 3,600 |
| Sale of previously written down inventory | (1,726) | (1,105) | (472) | (3,155) | (1,787) |
| $5,454 | $6,640 | $9,206 | $16,930 | $17,328 |
(2) For the quarters ended September 28, 2025, and June 29, 2025, and the nine months ended September 28, 2025, selling and administrative expenses included $1.1 million, $1.1 million, and $2.9 million, respectively, of expenses directly related to a planned ERP system implementation. For the nine months ended September 29, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne executives' retirement agreements.
(3) Restructuring and other consists of:
| Quarter Ended | Nine Months Ended |
|---|
| September 28, 2025 | June 29, 2025 | September 29, 2024 | September 28, 2025 | September 29, 2024 |
|---|
| Employee severance (a) | $4,786 | $2,320 | $1,280 | $18,501 | $5,319 |
| Lease terminations | 328 | 72 | - | 1,542 | - |
| Acquisition and divestiture related expenses | 173 | (422) | - | 2,043 | 2,214 |
| Other | 1,298 | 402 | 3,298 | 1,386 | 3,485 |
| $6,585 | $2,372 | $4,578 | $23,472 | $11,018 |
(a) For the nine months ended September 28, 2025, employee severance relates primarily to Robotics restructuring which impacted approximately 150 employees.
(4) On May 27, 2024, Teradyne sold Teradyne's Device Interface Solution ("DIS") business, a component of the Semiconductor Test segment, to Technoprobe S.p.A. ("Technoprobe"), for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.
(5) Interest and other includes:
| Quarter Ended | Nine Months Ended |
|---|
| September 28, 2025 | June 29, 2025 | September 29, 2024 | September 28, 2025 | September 29, 2024 |
|---|
| Pension settlement loss (gain) | $(800) | $ - | $ - | $(800) | $ - |
| Pension actuarial losses (gains) | - | 127 | (2,262) | 127 | (2,513) |
| Loss (gain) on foreign exchange contract | - | - | - | (561) | 9,765 |
(6) Under GAAP, when calculating diluted earnings per share, convertible debt must be assumed to have converted if the effect on EPS would be dilutive. Diluted shares assume the conversion of the convertible debt as the effect would be dilutive. Accordingly, for the quarter ended September 29, 2024, diluted shares included 0.5 million shares from the convertible note hedge transaction. For the nine months ended September 29, 2024, diluted shares included 4.8 million shares from the convertible note hedge transaction.
CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands)
| September 28, 2025 | December 31, 2024 |
|---|
| Assets | | |
| Cash and cash equivalents | $272,700 | $553,354 |
| Marketable securities | 25,017 | 46,312 |
| Accounts receivable, net | 593,800 | 471,426 |
| Inventories, net | 366,752 | 298,492 |
| Prepayments | 469,240 | 429,086 |
| Other current assets | 22,649 | 17,727 |
| Total current assets | 1,750,158 | 1,816,397 |
| Property, plant and equipment, net | 569,939 | 508,171 |
| Operating lease right-of-use assets, net | 62,442 | 70,185 |
| Marketable securities | 129,658 | 124,121 |
| Deferred tax assets | 253,455 | 222,438 |
| Retirement plans assets | 12,702 | 11,994 |
| Equity method investment | 538,001 | 494,494 |
| Other assets | 73,118 | 49,620 |
| Acquired intangible assets, net | 54,708 | 15,927 |
| Goodwill | 519,550 | 395,367 |
| Total assets | $3,963,731 | $3,708,714 |
| Liabilities | | |
| Accounts payable | $227,850 | $134,792 |
| Accrued employees’ compensation and withholdings | 203,850 | 204,991 |
| Deferred revenue and customer advances | 133,050 | 107,710 |
| Other accrued liabilities | 138,717 | 90,777 |
| Operating lease liabilities | 19,026 | 18,699 |
| Short-term debt | 200,000 | - |
| Income taxes payable | 72,496 | 67,610 |
| Total current liabilities | 994,989 | 624,579 |
| Retirement plans liabilities | 142,680 | 133,338 |
| Long-term deferred revenue and customer advances | 43,887 | 40,505 |
| Deferred tax liabilities | 6,890 | 1,038 |
| Long-term other accrued liabilities | 8,285 | 7,442 |
| Long-term operating lease liabilities | 49,725 | 57,922 |
| Long-term income taxes payable | - | 24,596 |
| Total liabilities | 1,246,456 | 889,420 |
| Shareholders’ equity | 2,717,275 | 2,819,294 |
| Total liabilities and shareholders’ equity | $3,963,731 | $3,708,714 |
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands)
| Quarter Ended | Nine Months Ended |
|---|
| September 28, 2025 | September 29, 2024 | September 28, 2025 | September 29, 2024 |
|---|
| Cash flows from operating activities: | | | | |
| Net income | $119,558 | $145,649 | $296,827 | $396,119 |
| Adjustments to reconcile net income to net cash provided by operating activities: | | | | |
| Depreciation | 26,649 | 25,553 | 79,484 | 74,480 |
| Stock-based compensation | 15,531 | 14,574 | 47,561 | 45,267 |
| Equity in net earnings of affiliate | 5,198 | 1,075 | 16,709 | 1,075 |
| Amortization | 3,867 | 4,736 | 12,723 | 14,133 |
| Provision for excess and obsolete inventory | 6,829 | 6,078 | 19,175 | 15,516 |
| Losses (gains) on investments | (3,644) | (2,951) | (4,722) | 10,139 |
| Loss (gain) on sale of business | - | - | - | (57,486) |
| Deferred taxes | (14,101) | (9,431) | (29,100) | (26,261) |
| Retirement plan actuarial losses (gains) | (800) | (2,262) | (673) | (2,512) |
| Other | 175 | (6,282) | 3,344 | (5,041) |
| Changes in operating assets and liabilities, net of businesses acquired: | | | | |
| Accounts receivable | (161,283) | (11,055) | (111,787) | (65,266) |
| Inventories | (10,911) | (5,974) | (34,618) | 11,127 |
| Prepayments and other assets | (53,478) | 39,248 | (22,599) | 61,438 |
| Accounts payable and other liabilities | 104,311 | (10,657) | 121,447 | (63,666) |
| Deferred revenue and customer advances | 12,596 | 885 | 25,652 | 3,624 |
| Retirement plans contributions | (1,410) | (1,395) | (6,986) | (4,169) |
| Income taxes | (36) | (21,520) | (19,661) | (18,898) |
| Net cash provided by operating activities | 49,051 | 166,271 | 392,776 | 389,619 |
| Cash flows from investing activities: | | | | |
| Purchases of property, plant and equipment | (46,692) | (51,841) | (161,121) | (140,710) |
| Investments in businesses | (20,151) | (2,407) | (25,519) | (527,060) |
| Purchases of marketable securities | (10,315) | (7,340) | (27,465) | (35,097) |
| Acquisitions of businesses, net of cash and cash equivalents | - | - | (144,380) | - |
| Proceeds from the sale of a business, net of cash and cash equivalents sold | - | 3,176 | - | 90,348 |
| Proceeds from maturities of marketable securities | 9,018 | 6,305 | 41,621 | 33,163 |
| Proceeds from sales of marketable securities | 684 | 2,311 | 9,172 | 23,600 |
| Proceeds from life insurance | - | - | - | 873 |
| Net cash used for investing activities | (67,456) | (49,796) | (307,692) | (554,883) |
| Cash flows from financing activities: | | | | |
| Proceeds from borrowings on revolving credit facility | 200,000 | - | 200,000 | 185,000 |
| Payments of borrowings on revolving credit facility | - | - | - | (185,000) |
| Dividend payments | (18,990) | (19,566) | (57,574) | (56,936) |
| Repurchase of common stock | (243,785) | (24,747) | (518,658) | (55,053) |
| Payments related to net settlement of employee stock compensation awards | (300) | (399) | (15,254) | (13,833) |
| Issuance of common stock under stock purchase and stock option plans | 15,284 | 15,429 | 30,076 | 37,265 |
| Net cash used for financing activities | (47,791) | (29,283) | (361,410) | (88,557) |
| Effects of exchange rate changes on cash and cash equivalents | (356) | 940 | (4,328) | 6,286 |
| (Decrease) increase in cash and cash equivalents | (66,552) | 88,132 | (280,654) | (247,535) |
| Cash and cash equivalents at beginning of period | 339,252 | 421,904 | 553,354 | 757,571 |
| Cash and cash equivalents at end of period | $272,700 | $510,036 | $272,700 | $510,036 |
GAAP to Non-GAAP Earnings Reconciliation
(In millions, except per share amounts)
| Quarter Ended |
|---|
| September 28, 2025 | % of Net Revenues | June 29, 2025 | % of Net Revenues | September 29, 2024 | % of Net Revenues |
|---|
| Net revenues | $769.2 | | $651.8 | | $737.3 | |
| Gross profit GAAP | 449.3 | 58.4% | 373.0 | 57.2% | 436.5 | 59.2% |
| Inventory step-up | 0.4 | 0.1% | 0.3 | 0.0% | - | - |
| Legal settlement (1) | - | - | - | - | 3.6 | 0.5% |
| Gross profit non-GAAP | 449.7 | 58.5% | 373.3 | 57.3% | 440.1 | 59.7% |
| Income from operations - GAAP | 145.3 | 18.9% | 90.7 | 13.9% | 152.1 | 20.6% |
| Restructuring and other (2) | 6.6 | 0.9% | 2.4 | 0.4% | 4.6 | 0.6% |
| Acquired intangible assets amortization | 3.5 | 0.5% | 3.7 | 0.6% | 4.7 | 0.6% |
| ERP related expenses (3) | 1.1 | 0.1% | 1.1 | 0.2% | - | - |
| Inventory step-up | 0.4 | 0.1% | 0.3 | 0.0% | - | - |
| Legal settlement (1) | - | - | - | - | 3.6 | 0.5% |
| Income from operations - non-GAAP | $156.9 | 20.4% | $98.2 | 15.1% | $165.0 | 22.4% |
| | | Net Income per Common Share | | | Net Income per Common Share | | | Net Income per Common Share |
|---|
| September 28, 2025 | % of Net Revenues | Basic | Diluted | June 29, 2025 | % of Net Revenues | Basic | Diluted | September 29, 2024 | % of Net Revenues | Basic | Diluted |
|---|
| Net income - GAAP | $119.6 | 15.5% | $0.75 | $0.75 | $78.4 | 12.0% | $0.49 | $0.49 | $145.6 | 19.7% | $0.89 | $0.89 |
| Amortization of equity method investment | 7.7 | 1.0% | 0.05 | 0.05 | 7.4 | 1.1% | 0.05 | 0.05 | 2.4 | 0.3% | 0.01 | 0.01 |
| Restructuring and other (2) | 6.6 | 0.9% | 0.04 | 0.04 | 2.4 | 0.4% | 0.02 | 0.01 | 4.6 | 0.6% | 0.03 | 0.03 |
| Acquired intangible assets amortization | 3.5 | 0.5% | 0.02 | 0.02 | 3.7 | 0.6% | 0.02 | 0.02 | 4.7 | 0.6% | 0.03 | 0.03 |
| ERP related expenses (3) | 1.1 | 0.1% | 0.01 | 0.01 | 1.1 | 0.2% | 0.01 | 0.01 | - | - | - | - |
| Inventory step-up | 0.4 | 0.1% | 0.00 | 0.00 | 0.3 | 0.0% | 0.00 | 0.00 | - | 0.0% | - | - |
| Pension settlement loss (gain) | (0.8) | -0.1% | (0.01) | (0.01) | - | - | - | - | - | - | - | - |
| Pension mark-to-market adjustment (4) | - | - | - | - | 0.1 | 0.0% | 0.00 | 0.00 | (2.3) | -0.3% | (0.01) | (0.01) |
| Legal settlement (1) | - | - | - | - | - | - | - | - | 3.6 | 0.5% | 0.02 | 0.02 |
| Exclude discrete tax adjustments | (0.6) | -0.1% | (0.00) | (0.00) | 0.0 | 0.0% | 0.00 | 0.00 | (8.9) | -1.2% | (0.05) | (0.05) |
| Non-GAAP tax adjustments | (1.6) | -0.2% | (0.01) | (0.01) | (1.8) | -0.3% | (0.01) | (0.01) | (2.1) | -0.3% | (0.01) | (0.01) |
| Net income - non-GAAP | $135.9 | 17.7% | $0.86 | $0.85 | $91.6 | 14.1% | $0.57 | $0.57 | $147.6 | 20.0% | $0.91 | $0.90 |
| GAAP and non-GAAP weighted average common shares - basic | 158.6 | | | | 160.0 | | | | 163.0 | | | |
| GAAP and non-GAAP weighted average common shares - diluted (5) | 159.1 | | | | 160.1 | | | | 164.3 | | | |
(1) For the three months ended September 29, 2024, legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.
(2) Restructuring and other consists of:
| Quarter Ended |
|---|
| September 28, 2025 | June 29, 2025 | September 29, 2024 |
|---|
| Employee severance | $4.8 | $2.3 | $1.3 |
| Lease terminations | 0.3 | 0.1 | - |
| Acquisition and divestiture related expenses | 0.2 | (0.4) | - |
| Other | 1.3 | 0.4 | 3.3 |
| $6.6 | $2.4 | $4.6 |
(3) For the quarters ended September 28, 2025, and June 29, 2025, selling and administrative expenses included costs directly related to a planned ERP system implementation.
(4) For the quarters ended June 29, 2025, and September 29, 2024, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.
(5) For the quarter ended September 29, 2024, non-GAAP weighted average diluted common shares included 0.5 million shares from the convertible note hedge transaction.
| Nine Months Ended |
|---|
| September 28, 2025 | % of Net Revenues | September 29, 2024 | % of Net Revenues |
|---|
| Net Revenues | $2,106.7 | | $2,067.0 | |
| Gross profit GAAP | 1,237.7 | 58.8% | 1,201.6 | 58.1% |
| Inventory step-up | 0.9 | 0.0% | - | - |
| Legal settlement (1) | - | - | 3.6 | 0.2% |
| Gross profit non-GAAP | 1,238.6 | 58.8% | 1,205.2 | 58.3% |
| Income from operations - GAAP | 356.9 | 16.9% | 440.2 | 21.3% |
| Restructuring and other (2) | 23.5 | 1.1% | 11.0 | 0.5% |
| Acquired intangible assets amortization | 11.8 | 0.6% | 14.1 | 0.7% |
| ERP related expenses (3) | 2.9 | 0.1% | - | - |
| Inventory step-up | 0.9 | 0.0% | - | - |
| Legal settlement (1) | - | - | 3.6 | 0.2% |
| Equity modification charge (4) | - | - | 1.7 | 0.1% |
| Loss (gain) on sale of business (5) | - | - | (57.5) | -2.8% |
| Income from operations - non-GAAP | $396.0 | 18.8% | $413.1 | 20.0% |
| | | Net Income per Common Share | | | Net Income per Common Share |
|---|
| September 28, 2025 | % of Net Revenues | Basic | Diluted | September 29, 2024 | % of Net Revenues | Basic | Diluted |
|---|
| Net income - GAAP | $296.8 | 14.1% | $1.86 | $1.85 | $396.1 | 19.2% | $2.51 | $2.42 |
| Restructuring and other (2) | 23.5 | 1.1% | 0.15 | 0.15 | 11.0 | 0.5% | 0.07 | 0.07 |
| Amortization of equity method investment | 22.5 | 1.1% | 0.14 | 0.14 | 2.4 | 0.1% | 0.02 | 0.01 |
| Acquired intangible assets amortization | 11.8 | 0.6% | 0.07 | 0.07 | 14.1 | 0.7% | 0.09 | 0.09 |
| ERP related expenses (3) | 2.9 | 0.1% | 0.02 | 0.02 | - | - | - | - |
| Inventory step-up | 0.9 | 0.0% | 0.01 | 0.01 | - | - | - | - |
| Pension mark-to-market adjustment (6) | 0.1 | 0.0% | 0.00 | 0.00 | (2.5) | -0.1% | (0.02) | (0.02) |
| Loss (gain) on foreign exchange contract | (0.6) | 0.0% | (0.00) | (0.00) | 9.8 | 0.5% | 0.06 | 0.06 |
| Pension settlement loss (gain) | (0.8) | 0.0% | (0.01) | (0.00) | - | - | - | - |
| Legal settlement (1) | - | - | - | - | 3.6 | 0.2% | 0.02 | 0.02 |
| Equity modification charge (4) | - | - | - | - | 1.7 | 0.1% | 0.01 | 0.01 |
| Loss (gain) on sale of business (5) | - | - | - | - | (57.5) | -2.8% | (0.36) | (0.35) |
| Exclude discrete tax adjustments | 0.4 | 0.0% | 0.00 | 0.00 | (0.7) | 0.0% | (0.00) | (0.00) |
| Non-GAAP tax adjustments | (8.4) | -0.4% | (0.05) | (0.05) | (7.9) | -0.4% | (0.05) | (0.05) |
| Net income - non-GAAP | $349.1 | 16.6% | $2.18 | $2.18 | $370.1 | 17.9% | $2.34 | $2.26 |
| GAAP and non-GAAP weighted average common shares - basic | 160.0 | | | | 158.0 | | | |
| GAAP and non-GAAP weighted average common shares - diluted (7) | 160.4 | | | | 163.4 | | | |
(1) For the nine months ended September 29, 2024, legal settlement includes charges for a settlement following a judgment against the Company for infringement of expired patents.
(2) Restructuring and other consists of:
| Nine Months Ended |
|---|
| September 28, 2025 | September 29, 2024 |
|---|
| Employee severance (a) | $18.5 | $5.3 |
| Acquisition and divestiture related expenses | 2.0 | 2.2 |
| Lease terminations | 1.5 | - |
| Other | 1.4 | 3.5 |
| $23.4 | $11.0 |
(a) For the nine months ended September 28, 2025, employee severance relates primarily to Robotics restructuring which impacted approximately 150 employees.
(3) For the nine months ended September 28, 2025, selling and administrative expenses included costs directly related to a planned ERP system implementation.
(4) For the nine months ended September 29, 2024, selling and administrative expenses included an equity charge of $1.7 million for the modification of Teradyne’s executives' retirement agreements.
(5) On May 27, 2024, Teradyne sold DIS, a component of the Semiconductor Test segment, to Technoprobe, for $85.0 million, net of cash and cash equivalents sold and a working capital adjustment.
(6) For the nine months ended September 28, 2025, and September 29, 2024, adjustments to exclude actuarial gains and losses, respectively, recognized under GAAP in accordance with Teradyne’s mark-to-market pension accounting.
(7) For the nine months ended September 29, 2024, non-GAAP weighted average diluted common shares included 4.8 million shares from the convertible note hedge transaction.
GAAP to Non-GAAP Reconciliation of Fourth Quarter 2025 guidance:
| GAAP and non-GAAP fourth quarter revenue guidance: | $920 million | to | $1,000 million |
| GAAP net income per diluted share | $1.12 | | $1.39 |
| Exclude acquired intangible assets amortization | 0.03 | | $0.03 |
| Exclude equity method investment amortization | 0.05 | | $0.05 |
| Non-GAAP tax adjustments | (0.01) | | $(0.01) |
| Non-GAAP net income per diluted share | $1.20 | | $1.46 |
For press releases and other information of interest to investors, please visit Teradyne’s homepage at http://www.teradyne.com.
Contacts
Teradyne, Inc. · Amy McAndrews 978-370-3945 · Vice President of Corporate Relations